Development of an anti-angiogenic targeted toxin against glioblastoma multiforme

被引：0
|
作者：
Hall, WA
Rustamzadeh, E
Liu, H
Vallera, DA
机构：
[1] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Radiat Oncol, Minneapolis, MN 55455 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
412
引用
收藏
页码：S124 / S124
页数：1
相关论文
共 50 条
  • [31] Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
    Hanwool Jeon
    Joonho Byun
    Hayeong Kang
    Kyunggon Kim
    Eunyeup Lee
    Jeong Hoon Kim
    Chang Ki Hong
    Sang Woo Song
    Young-Hoon Kim
    Sangjoon Chong
    Jae Hyun Kim
    Soo Jeong Nam
    Ji Eun Park
    Seungjoo Lee
    Journal of Translational Medicine, 21
  • [32] METABOLIC ANALYSIS OF GLIOBLASTOMA XENOGRAFTS AFTER ANTI-ANGIOGENIC TREATMENT
    Fack, F.
    Zheng, L.
    Frezza, C.
    Keunen, O.
    Kalna, G.
    Nazarov, P.
    Gottlieb, E.
    Niclou, S. P.
    Bjerkvig, R.
    NEURO-ONCOLOGY, 2012, 14 : 58 - 58
  • [33] Identification of the hidden survival advantage for anti-angiogenic therapy in glioblastoma
    Nabors, Burt
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (01) : 72 - 74
  • [34] A is for anti-angiogenic
    不详
    NATURE MEDICINE, 2001, 7 (04) : 418 - 418
  • [35] Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma
    Dietrich, Joerg
    Wang, Daphne
    Batchelor, Tracy T.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (10) : 1549 - 1557
  • [36] ANTI-ANGIOGENIC ISOFORMS OF VEGF - A KEY TO ANTI-ANGIOGENIC THERAPY
    Bates, D. O.
    Harper, S. J.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3207 - 3208
  • [37] Diphtheria toxin-based targeted toxins that target glioblastoma multiforme
    Hall, Walter A.
    Li, Yan Michael
    Vallera, Daniel A.
    TOXIN REVIEWS, 2014, 33 (03) : 119 - 124
  • [38] The development of anti-angiogenic heparan sulfate oligosaccharides
    Jayson, Gordon C.
    Miller, Gavin J.
    Hansen, Steen U.
    Barath, Marek
    Gardiner, John M.
    Avizienyte, Egle
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2014, 42 : 1596 - 1600
  • [39] Development of an anti-angiogenic vaccine targeting VEGF
    Wentink, Madelon Q.
    Griffioen, Arjan W.
    Timmerman, Peter
    de Gruijl, Tanja D.
    Verheul, Henk M. W.
    ANGIOGENESIS, 2014, 17 (03) : 772 - 773
  • [40] Clinical development of anti-angiogenic agents in 2002
    Bachelot, T
    Jouanneau, E
    Blay, JY
    BULLETIN DU CANCER, 2003, 90 (01) : 19 - 23
12345